Skip to content
10-K/A

Annual Report

CEREVEL THERAPEUTICS HOLDINGS, INC.

0001193125-23-149281

← back to feed
Filed
May 19, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Feb 10, 2023 156.66M sh